These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 20886385

  • 1. Cell therapy for peripheral arterial disease.
    Menasché P.
    Curr Opin Mol Ther; 2010 Oct; 12(5):538-45. PubMed ID: 20886385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
    Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H, TACT Follow-up Study Investigators.
    Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review.
    Attanasio S, Snell J.
    Cardiol Rev; 2009 Nov; 17(3):115-20. PubMed ID: 19384084
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation?
    Collinson DJ, Donnelly R.
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):9-23. PubMed ID: 15177227
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Progenitor cell therapy in patients with critical limb ischemia without surgical options.
    Sprengers RW, Lips DJ, Moll FL, Verhaar MC.
    Ann Surg; 2008 Mar; 247(3):411-20. PubMed ID: 18376183
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preclinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy.
    Nikol S, Huehns TY.
    J Invasive Cardiol; 2001 Apr; 13(4):333-8. PubMed ID: 11287726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cell therapy for cardiovascular disease: what cells, what diseases and for whom?
    Caplice NM, Gersh BJ, Alegria JR.
    Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):37-43. PubMed ID: 16265341
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.